Advertisement

Self-Renewing T Cells

The homeostasis of cell populations within an organism can be achieved through a variety of mechanisms, including the differentiation of precursor populations, self-renewal of terminally differentiated cells, or by programming cells to be extremely long-lived. Regulatory T cells that express the transcription factor Foxp3 are critical for maintaining immune tolerance by preventing excessive inflammation and autoimmunity. Rubtsov et al. (p. 1667) now use genetic fate mapping and cell transfer studies in vivo to demonstrate that Foxp3-expressing cells are remarkably stable under both basal and inflammatory conditions. Thus, regulatory T cells appear to be maintained through self-renewal and should maintain their identity if used in adoptive cell therapies for treatment of autoimmunity or other inflammatory disorders.

Abstract

Tissue maintenance and homeostasis can be achieved through the replacement of dying cells by differentiating precursors or self-renewal of terminally differentiated cells or relies heavily on cellular longevity in poorly regenerating tissues. Regulatory T cells (Treg cells) represent an actively dividing cell population with critical function in suppression of lethal immune-mediated inflammation. The plasticity of Treg cells has been actively debated because it could factor importantly in protective immunity or autoimmunity. By using inducible labeling and tracking of Treg cell fate in vivo, or transfers of highly purified Treg cells, we have demonstrated notable stability of this cell population under physiologic and inflammatory conditions. Our results suggest that self-renewal of mature Treg cells serves as a major mechanism of maintenance of the Treg cell lineage in adult mice.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (rubtsov-som.pdf)

References and Notes

1
el Marjou F., et al., Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39, 186 (2004).
2
Dor Y., Brown J., Martinez O. I., Melton D. A., Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429, 41 (2004).
3
Fontenot J. D., Gavin M. A., Rudensky A. Y., Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330 (2003).
4
Fontenot J. D., et al., Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22, 329 (2005).
5
Hori S., Takahashi T., Sakaguchi S., Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv. Immunol. 81, 331 (2003).
6
Khattri R., Cox T., Yasayko S.-A., Ramsdell F., An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4, 337 (2003).
7
Kim J. M., Rasmussen J. P., Rudensky A. Y., Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191 (2007).
8
Apostolou I., Sarukhan A., Klein L., von Boehmer H., Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3, 756 (2002).
9
Hsieh C.-S., et al., Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21, 267 (2004).
10
Jordan M. S., et al., Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2, 301 (2001).
11
Pacholczyk R., Ignatowicz H., Kraj P., Ignatowicz L., Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity 25, 249 (2006).
12
Williams L. M., Rudensky A. Y., Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8, 277 (2007).
13
Materials and methods are available as supporting material on Science Online.
14
Liao W., et al., Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression. Nat. Immunol. 9, 1288 (2008).
15
Burchill M. A., Yang J., Vogtenhuber C., Blazar B. R., Farrar M. A., IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178, 280 (2007).
16
Setoguchi R., Hori S., Takahashi T., Sakaguchi S., Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201, 723 (2005).
17
Fontenot J. D., Rasmussen J. P., Gavin M. A., Rudensky A. Y., A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142 (2005).
18
Bayer A. L., Yu A., Malek T. R., Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells. J. Immunol. 178, 4062 (2007).
19
Malek T. R., et al., IL-2 family of cytokines in T regulatory cell development and homeostasis. J. Clin. Immunol. 28, 635 (2008).
20
Oldenhove G., et al., Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31, 772 (2009).
21
Zhou X., Bailey-Bucktrout S., Jeker L. T., Bluestone J. A., Plasticity of CD4+ FoxP3+ T cells. Curr. Opin. Immunol. 21, 281 (2009).
22
Koch M. A., et al., The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10, 595 (2009).
23
Katz J. D., Wang B., Haskins K., Benoist C., Mathis D., Following a diabetogenic T cell from genesis through pathogenesis. Cell 74, 1089 (1993).
24
Wu H. J., et al., Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32, 815 (2010).
25
Zhou X., et al., Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000 (2009).
26
Tsuji M., et al., Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer’s patches. Science 323, 1488 (2009).
27
Zhou L., et al., TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORgammat function. Nature 453, 236 (2008).
28
Zheng Y., et al., Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808 (2010).

(0)eLetters

eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.

Log In to Submit a Response

No eLetters have been published for this article yet.

Information & Authors

Information

Published In

Science
Volume 329 | Issue 5999
24 September 2010

Submission history

Received: 7 May 2010
Accepted: 2 August 2010
Published in print: 24 September 2010

Permissions

Request permissions for this article.

Acknowledgments

We thank K. Forbush, T. Chu, L. Karpik, A. Bravo, J. Herlihy, P. Zarin, G. Gerard, A. Ortiz-Lopes, and K. Hattori for assistance with mouse colony management; F. Costantini for R26Y mice; V. Kuchroo for Foxp3-IRES-GFP mice; P. Chambon for Cre-ERT2 plasmid; E. Pamer, C. Shi, and E. Leiner for L. monocytogenes and assistance with experiments; and P. Fink and K. Simmons for cells from Rag2pGFP mice and helpful discussion. R.E.N. was supported by NIH Medical Scientist Training Program grant GM07739. A.Y.R. is an investigator with the Howard Hughes Medical Institute, and this work was also supported by grant AI51530 from the NIH to C.B. and D.M.

Authors

Affiliations

Yuri P. Rubtsov*
Howard Hughes Medical Institute and Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Present address: Department of Fundamental Medicine, Moscow State University, Moscow 117192, Russian Federation.
Rachel E. Niec*
Howard Hughes Medical Institute and Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Steven Josefowicz
Howard Hughes Medical Institute and Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Li Li
Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.
Jaime Darce
Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.
Diane Mathis
Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.
Christophe Benoist
Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.
Alexander Y. Rudensky [email protected]
Howard Hughes Medical Institute and Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

Notes

*
These authors contributed equally to this work.
To whom correspondence should be addressed. E-mail: [email protected]

Metrics & Citations

Metrics

Article Usage

Altmetrics

Citations

Cite as

Export citation

Select the format you want to export the citation of this publication.

Cited by

  1. Regulatory T cells in skin mediate immune privilege of the hair follicle stem cell niche, Science Immunology, 9, 91, (2024)./doi/10.1126/sciimmunol.adh0152
    Abstract
  2. Regulatory T cells engineered with TCR signaling–responsive IL-2 nanogels suppress alloimmunity in sites of antigen encounter, Science Translational Medicine, 12, 569, (2021)./doi/10.1126/scitranslmed.aaw4744
    Abstract
  3. Regulation of immune responses to protein therapeutics by transplacental induction of T cell tolerance, Science Translational Medicine, 7, 275, (275ra21-275ra21), (2021)./doi/10.1126/scitranslmed.aaa1957
    Abstract
  4. Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease, Science Translational Medicine, 5, 179, (179ra43-179ra43), (2021)./doi/10.1126/scitranslmed.3005265
    Abstract
  5. CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients, Science Translational Medicine, 4, 134, (134ra62-134ra62), (2021)./doi/10.1126/scitranslmed.3003330
    Abstract
  6. Altered homeostasis and development of regulatory T cell subsets represent an IL-2R–dependent risk for diabetes in NOD mice, Science Signaling, 10, 510, (2021)./doi/10.1126/scisignal.aam9563
    Abstract
  7. Redundant and specialized roles for diacylglycerol kinases α and ζ in the control of T cell functions, Science Signaling, 8, 374, (re6-re6), (2021)./doi/10.1126/scisignal.aaa0974
    Abstract
  8. Regulatory T cells promote innate inflammation after skin barrier breach via TGF-β activation, Science Immunology, 6, 62, (2021)./doi/10.1126/sciimmunol.abg2329
    Abstract
  9. Unstable regulatory T cells, enriched for naïve and Nrp1neg cells, are purged after fate challenge, Science Immunology, 6, 61, (2021)./doi/10.1126/sciimmunol.abe4723
    Abstract
  10. Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding, Science Immunology, 5, 49, (2021)./doi/10.1126/sciimmunol.abc2728
    Abstract
  11. See more
Loading...

View Options

Check Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.

More options

Register for free to read this article

As a service to the community, this article is available for free. Login or register for free to read this article.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View options

PDF format

Download this article as a PDF file

Download PDF

Full Text

FULL TEXT

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media